secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2026-08-25T21:00:56+00:00
Accession:  0001213900-26-093566
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative Therapies receives Nasdaq delisting notice for late 10-Q filing
------------------------------------------------------------------------------

- Received Nasdaq delinquency notice on Aug 21, 2026 for failure to file Form 10-Q for Q2 2026.
- Must submit compliance plan by Oct 20, 2026; Nasdaq may grant extension until Feb 16, 2027.
- Listing continues on Nasdaq Capital Market under BRTX; no immediate delisting effect.
- Company plans to file 10-Q and submit plan; may appeal if plan rejected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000121390026093566/0001213900-26-093566-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000121390026093566/ea0303388-8k_biorestorative.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-093566

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer